Geneos Wealth Management’s T. Rowe Price US Equity Research ETF TSPA Stock Holding History

Geneos Wealth Management’s Portfolio TSPA Stock Details TSPA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$23.7M	Sell	497,990 -801	-0.2%	-$36.7K	0.48%	47
2026 Q1	$20.4M	Buy	498,791 +2,161	+0.4%	+$92.3K	0.47%	46
2025 Q4	$21.2M	Buy	496,630 +17,736	+4%	+$754K	0.52%	40
2025 Q3	$20.1M	Buy	478,894 +9,980	+2%	+$402K	0.51%	40
2025 Q2	$18.2M	Buy	468,914 +9,472	+2%	+$341K	0.45%	48
2025 Q1	$16.2M	Buy	459,442 +459,210	+197,935%	+$17M	0.54%	34
2024 Q4	$8.58K	Buy	+232	New	+$8.61K	﹤0.01%	2110

Other funds holding TSPA

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

National Pension Service Jeonju-Si, Jeollabuk-Do, South Korea $155B AUM 42.54% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

M&T Bank Buffalo, New York $34.1B AUM 29.18% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

FMWA

Forvis Mazars Wealth Advisors Springfield, Missouri $5.99B AUM 21.91% 1-Year Est. Return

Allworth Financial Folsom, California $23.6B AUM 20.99% 1-Year Est. Return

PWM

Provident Wealth Management Brentwood, Tennessee $388M AUM 20.98% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Geneos Wealth Management's TSPA Position: Q2 2026 in Review

Geneos Wealth Management reduced its T. Rowe Price US Equity Research ETF (TSPA) stake by 0.16% in Q2 2026, selling an estimated $36.7K and leaving 497,990 shares worth $23.7M. The position accounts for 0.48% of the portfolio, ranked #47.

Geneos Wealth Management first reported a position in TSPA in Q4 2024 and has held it in 7 quarters since. 137 funds tracked by Wall St. Rank hold TSPA as of Q2 2026.

Geneos Wealth Management held 497,990 shares of T. Rowe Price US Equity Research ETF worth $23.7M as of Q2 2026.
Geneos Wealth Management sold 801 T. Rowe Price US Equity Research ETF shares in Q2 2026, an estimated $36.7K.
T. Rowe Price US Equity Research ETF made up 0.48% of Geneos Wealth Management's portfolio in Q2 2026, its #47 holding.
Geneos Wealth Management first reported a position in T. Rowe Price US Equity Research ETF in Q4 2024 and has held it in 7 quarters since.
137 funds tracked by Wall St. Rank held T. Rowe Price US Equity Research ETF as of Q2 2026.

Based on Geneos Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.